See inside every stock. Pro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI103.09▲ 3.64%
← DOCM page
XStocksXray
Market X-Ray report · 22 October 2026

DocMorris AG (DOCM)

SIX Swiss Exchange · Switzerland · prices in CHF · close of 22 Oct 2026

Key indicators

Last closeCHF 15.72
52-week range3.92 – 16.58
Return, 1 month / 3 months+35.4% / +48.3%
Return, 1 year / 3 years+192.7% / −13.5%
TrendUptrend
RSI (14)72
Volatility (1 year)58.2%
Worst drawdown (1 year)-39.7%
Average daily value traded5.19M CHF
Dividend yield–

Market X-Ray price-based

70/ 100 · High confidence · ahead of 86% of stocks on this exchange
Trend95
Momentum98
Stability (higher is calmer)16
Liquidity70
Income–

Five-year price chart navy: price · brown: 200-day average

-7.3045.3598.011512032021-102023-012024-042025-072026-10

About the company

DocMorris AG is a Swiss healthcare company that runs an online pharmacy and mail-order business, chiefly serving customers in Germany. It supplies prescription and over-the-counter medicines, health products and related wellness goods through its website and app, and it also operates a chain of physical pharmacies. The company is based in Switzerland and combines digital ordering with pharmaceutical advice and delivery services for private customers.

The shares are listed on the SIX Swiss Exchange in Switzerland under the code DOCM, and the price on this page is in Swiss francs (CHF). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

DocMorris AG (DOCM) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 15.72 on 22 October 2026.

Its price-based Market X-Ray is 70 out of 100 (a fair price profile), ranking 33 of 225 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 192.7% and over the last three months it rose 48.3%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
DocMorris AG (DOCM)

The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange

Lens and metricValueScoreReading
Trend95 · StrongTrading above its long-term averages and near its highs.
Above 200-day average92.7%
From 52-week high-2.2%
Momentum98 · StrongRising faster than most stocks on this exchange.
3-month return48.3%
6-month return124.6%
12-month return, skipping the last month116.2%
Stability (higher is calmer)16 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)58.2%
Worst drawdown, 1 year (smaller is calmer)-39.7%
Liquidity70 · FairModerate trading activity.
Average daily value traded5.19M CHF
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Trend: Trading above its long-term averages and near its highs.
  • Momentum: Rising faster than most stocks on this exchange.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week+7.8%
1 month+35.4%
3 months+48.3%
6 months+124.6%
1 year+192.7%
3 years−13.5%
5 years−91.1%

Signals

50-day / 200-day average11.73 / 8.16
Golden / death cross (60 days)None
New 52-week highYes
Bullish RSI divergenceNo
Average daily range (ATR)0.73

Technical summary

DailyBullish12 bullish · 0 neutral · 4 bearish
WeeklyStrongly bullish10 bullish · 0 neutral · 2 bearish
MonthlyBullish5 bullish · 1 neutral · 2 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 23 Oct 2026